BIIB Jan 2025 250.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:26AM EDT. Market open.
| Previous close | 0.8500 |
| Open | 0.6500 |
| Bid | 0.1000 |
| Ask | 1.0000 |
| Strike | 250.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.6500 - 0.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | 250 |
- Investing.com
UBS sees more downside and than upside in Biogen stock
Investing.com -- There is a higher potential for downside than upside in Biogen Inc's (NASDAQ:BIIB) shares, UBS analysts said Thursday, lowering their price target on the stock from $234 to $202.
Investor's Business DailyIs Eli Lilly Stock A Buy After Snagging Approval For A New Eczema Drug?
The Food and Drug Administration signed off on a new eczema drug from Eli Lilly. Is Eli Lilly stock a buy right now?
Simply Wall St.Investors in Biogen (NASDAQ:BIIB) have unfortunately lost 32% over the last three years
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...
© 2024 Yahoo. All rights reserved.